Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) General Information

Description

Portfolio of anti-diabetes trademarks.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Ingelheim Am Rhein
  • Germany
Primary Industry
Buildings and Property
Acquirer
Lupin
Corporate Office
  • Ingelheim Am Rhein
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)‘s full profile, request access.

Request a free trial

Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)‘s full profile, request access.

Request a free trial

Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) FAQs

  • Where is Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) headquartered?

    Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) is headquartered in Ingelheim Am Rhein, Germany.

  • What industry is Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) in?

    Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)’s primary industry is Buildings and Property.

  • Is Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) a private or public company?

    Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) is a Private company.

  • What is the current valuation of Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)?

    The current valuation of Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) is .

  • What is Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)’s current revenue?

    The current revenue for Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) is .

  • Who are Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)’s investors?

    Boehringer Ingelheim has invested in Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO).

  • When was Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) acquired?

    Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) was acquired on 13-Dec-2025.

  • Who acquired Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO)?

    Boehringer Ingelheim (Anti-Diabetes Trademarks GIBTULIO, GIBTULIO MET and AJADUO) was acquired by Lupin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process